A Novi-based medical device company focused on better detecting breast cancer is moving toward widespread commercialization, having completed a new $30 million venture capital funding round.Delphinus Medical Technologies Inc., a spin-out from the Barbara Ann Karmanos Cancer Institute in Detroit, is…
/PRNewswire/ The Barbara Ann Karmanos Cancer Institute, the world-renowned, Detroit-based National Cancer Institute-Designated Comprehensive Cancer Center,.
[343 Pages Report] The breast imaging market is expected to increase at a 7.1% CAGR from an anticipated USD 4.3 billion in 2022 to USD 8.5 billion by 2032.Technological improvements, the rising prevalence of breast cancer, the increasing number of screening programs, and the increasing number of conferences and symp.